Please correct me if I am reading these reports wrong.

New Post Public Reply Private Reply Replies (1) Message Board
mikeo73 ih8aloss #20341
540
Please correct me if I am reading these reports wrong. Also, I haven't combed through all the shares that were issued since the last annual report came out, so the number may be a little low. But also the table stated it was using numbers from March 14, 2021 so it might not be that far off. Anyway I think the amount of issue shares for Pasaca to get to 51% would be much less than you are thinking. From the last 10-K page 55:

Pasaca Capital, Inc. (10) 249,661,287 26.5%
Includes 249,661,287 shares of common stock issuable upon conversion of debentures.
Percentages in the table were based upon 693,367,942 common shares outstanding as of March 14, 2021.

Elsewhere in the report it states: As of March 19, 2021, the issuer had 699,339,396 shares of common stock, $0.001 par value per share outstanding.


Furthermore the agreement states:

On January 26, 2021, ..yada yada... The Senior Note is convertible into 154,228,625 shares of the Company’s common stock (the “Note Shares”).

Since the 10-K references percentages based upon common shares outstanding as of March 14th, 2021 I am assuming the 154M shares are included in the 249M number above.

At the second closing, Pasaca will purchase common stock of the Company (“Common Stock”) in an amount such that, after such purchase and the conversion of the Senior Note into the Note Shares, Pasaca will own fifty-one percent (51.0%) of the fully diluted common stock of the Company. The purchase price for the Common Stock to be sold in the second closing is $10,500,000.

So if my math is correct, roughly 220,000,000 share would need to be issued to get Pasaca to 51% and this in exchange for $10.5M.

Although it would have been nice if Pasaca were buying these shares on the open market like some people have suggested, reading the agreement I believe that was never intended. Furthermore I agree with you, the filing F... up was a major disaster and I am not in favor of a reverse split in the long term. However, I do not believe the deal is NOT all of a sudden a bad deal. With the current share price, Pasaca is trading $10.5M for $6.6M worth of stock. It is unfortunate that the share price is at where it is currently. However this deal actually adds shareholder value rather than lower it and the company is clearly in need of some management help. Lastly, a reverse split before or after issuance of Pasaca shares makes no difference. 51% remains 51%.



Quantum Materials Corp. (QTMM) Stock Research Links

QTMM Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ecozy's Brezzano Switch: Brewing Simplicity at Home

Updated Category News Views 288

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 327

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading
Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 102

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 238

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Muyuan Foods Spotlights Smart Farming at EuroTier 2026

Updated Category News Views 210

Muyuan Foods Ready to Impress at EuroTier 2026 Let's face it, folks—when you think of game-changers in pig farming, Muyuan Foods Group deserves a nod. They're not just trotting out oinkers left and right; they're steering the whole paddock with innovations in smart pig farming and green development solutions. At EuroTier 2026 in Hanover, Muyuan’s booth—J04 in Hall...

Continue Reading
JOYEE N01 Kicks Off Global Launch with African Orders

Updated Category News Views 230

A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 138

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
7th World Media Summit Spotlights Media's Future in Beijing

Updated Category News Views 140

The Changing Landscape of Global Media An event of this magnitude doesn't just pop up every day like a stock ticker on Wall Street. This year's 7th World Media Summit in Beijing is where nearly 500 bigwigs from all corners of the media landscape are converging. It's not about trading stocks or hitting quarterly numbers—it's about shaping how stories get told in an era...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 263

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Adding Fireplaces: Home Comfort or Construction Headache?

Updated Category News Views 175

Sizing Up the Installation Options Slapping a fireplace into a home sounds more like a pipe dream than a practical project for most folks. But according to fireplace whiz Jimmy Smith down in North Charleston, the times are a-changin'. These days, with advances in technology, homeowners can actually pull it off without collapsing their living room walls. Nitty-Gritty:...

Continue Reading

Top 5 Most Recently Viewed Articles

Strategic Offering: Capital Southwest's $350 Million Bond Deal

Updated Category News Views 209

Capital Southwest Corporation's Noteworthy Bond Offering Capital Southwest Corporation (NASDAQ: CSWC) has made headlines with its recent pricing of a public offering, amounting to a significant $350 million in 5.950% notes due in 2030. This strategic financial move showcases the Company’s commitment to expanding its investment capabilities while ensuring a stable...

Continue Reading
Nektar Therapeutics Enhances CAR-T Efficacy with NKTR-255

Updated Category News Views 392

Nektar Therapeutics Elevates CAR-T Therapy with NKTR-255 Nektar Therapeutics (Nasdaq: NKTR) has recently showcased remarkable findings from its Phase 2 clinical trial, emphasizing the efficacy of its investigational treatment NKTR-255. This new therapy aims to enhance the effectiveness of CD19-directed CAR-T cell therapy in patients suffering from relapsed or refractory...

Continue Reading
Motorcycle Accessories Market Expected to Hit $33.85 Billion

Updated Category News Views 132

Growth Potential in the Motorcycle Accessories Market The motorcycle accessories market is set for substantial growth, showing a remarkable increase from USD 21.18 billion in 2025 to an estimated USD 33.85 billion by 2034. This surge indicates a Compound Annual Growth Rate (CAGR) of 5.35%. Such an escalation in market size reflects broader trends in consumer behavior and...

Continue Reading
Dealerlogix Joins GM's 3Synergy Program to Enhance Services

Updated Category News Views 584

Dealerlogix Enters GM’s 3Synergy Program Dealerlogix, powered by Vehlo, has successfully joined General Motors' 3Synergy service lane tool program. This innovative fixed operations platform offers GM dealers a robust, all-in-one solution designed to enhance service department efficiency. With a range of customizable features, Dealerlogix aims to automate vital...

Continue Reading
Growth of PD-(L)1 Inhibitors in Oncology Highlighted by Trends

Updated Category News Views 140

Emerging Trends in the PD-(L)1 Inhibitors Market As innovations in immunotherapy continue to shape cancer treatment, the PD-(L)1 inhibitors market is witnessing significant growth. These therapies are redefining patient outcomes across various cancers, prompting both researchers and pharmaceutical companies to invest heavily in this evolving space. Understanding PD-(L)1...

Continue Reading